Treating Cluster Headache with Psychedelics
2019-05-31
Any discussion of cluster headache eventually includes treating cluster headache with psychedelics as an alternative to medical treatment.Read More →
Rapid and Sustained Symptom Reduction Following Psilocybin Treatment for Anxiety and Depression in Patients with Life-threatening Cancer
2016-11-30
Clinically significant anxiety and depression are common in patients with cancer, and are associated with poor psychiatric and medical outcomes. Historical and recent research suggests a role for psilocybin to treat cancer-related anxiety and depression.Read More →
Hallucinogens and related disorders
2015-08-12
Hallucinogens are as old as civilization. Many cultures recorded eating certain plants specifically to induce visions or alter the perception of reality. Often these hallucinations were part of a religious or prophetic experience. Shamans in Siberia were known to eat the hallucinogenic mushroom Amanita muscaria . The ancient Greeks and the Vikings also used naturally occurring plant hallucinogens. Peyote, a spineless cactus native to the southwestern United States and Mexico was used by native peoples, including the Aztecs, to produce visions.Read More →
Psychedelics: Considerations Before Use
2013-05-23
People have been talking about treating cluster headache with psychedelics for years. Here are some things to consider before making the choice.Read More →
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series
2010-03-26
Cluster headache (CH) is a stereotyped primary headache characterized by strictly unilateral severe orbital or periorbital pain and categorized as either episodic or chronic (1,2). Its prevalence is 0.1% (3). Oxygen and sumatriptan are the treatments of choice for individual attacks, whereas verapamil, lithium, corticosteroids and other neuromodulators can suppress attacks during cluster periods (1)Read More →
Response of cluster headache to psilocybin and LSD
2006-06-27
The authors interviewed 53 cluster headache patients who had used psilocybin or lysergic acid diethylamide (LSD) to treat their condition. Twenty-two of 26 psilocybin users reported that psilocybin aborted attacks; 25 of 48 psilocybin users and 7 of 8 LSD users reported cluster period termination; 18 of 19 psilocybin users and 4 of 5 LSD users reported remission period extension. Research on the effects of psilocybin and LSD on cluster headche may be warranted.
Read More →